Screener
Palvella Therapeutics PVLA Free cash flow
Discontinued — last reported Q3 '24
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Palvella Therapeutics’s reported figures.
The source filing: Palvella Therapeutics’s 10-Q, filed November 12, 2025. Open the filing →
- Filed
- Nov 12, 2025
- Fiscal quarter
- Q3 FY2025
- Calendar quarter
- Q3 2025
- Accession
- 0001193125-25-276119
FAQ
- What is Palvella Therapeutics's free cash flow?
- Palvella Therapeutics (PVLA) reported free cash flow of -$2.74M in Q3 2024.
- How has Palvella Therapeutics's free cash flow changed year-over-year?
- Palvella Therapeutics's free cash flow increased by 72.0% year-over-year, from -$9.79M to -$2.74M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Palvella Therapeutics's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude